CME Group (NASDAQ:CME) Issues Quarterly Earnings Results, Beats Estimates By $0.03 EPS

CME Group (NASDAQ:CME) posted its quarterly earnings data on Thursday, October 25th. The financial services provider reported $1.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.42 by $0.03, MarketWatch Earnings reports. The business had revenue of $904.20 million during the quarter, compared to analysts’ expectations of $910.50 million. CME Group had a net margin of 113.67% and a return on equity of 9.18%.

Shares of CME traded up $0.31 during mid-day trading on Friday, hitting $189.74. 2,459,969 shares of the company’s stock were exchanged, compared to its average volume of 2,184,394. CME Group has a twelve month low of $137.51 and a twelve month high of $190.43. The firm has a market cap of $64.06 billion, a price-to-earnings ratio of 39.78, a price-to-earnings-growth ratio of 2.19 and a beta of 0.49. The company has a quick ratio of 1.08, a current ratio of 1.09 and a debt-to-equity ratio of 0.15.

The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 27th. Stockholders of record on Monday, December 10th will be paid a dividend of $0.70 per share. The ex-dividend date is Friday, December 7th. This represents a $2.80 annualized dividend and a dividend yield of 1.48%. CME Group’s dividend payout ratio (DPR) is 58.70%.

In related news, insider Hilda Harris Piell sold 1,823 shares of the firm’s stock in a transaction on Tuesday, September 4th. The shares were sold at an average price of $175.00, for a total value of $319,025.00. Following the transaction, the insider now directly owns 30,176 shares in the company, valued at approximately $5,280,800. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Jeffrey M. Bernacchi sold 4,976 shares of the firm’s stock in a transaction on Tuesday, September 4th. The shares were sold at an average price of $176.60, for a total transaction of $878,761.60. Following the completion of the transaction, the director now owns 52,004 shares in the company, valued at $9,183,906.40. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 23,572 shares of company stock worth $4,206,309. 0.43% of the stock is currently owned by company insiders.

CME has been the subject of a number of research reports. Zacks Investment Research upgraded shares of CME Group from a “sell” rating to a “hold” rating in a report on Wednesday, October 3rd. Bank of America restated a “buy” rating and issued a $200.00 price target on shares of CME Group in a research report on Monday, November 5th. Jefferies Financial Group upped their price target on shares of CME Group to $203.00 and gave the company a “buy” rating in a research report on Monday, October 8th. BidaskClub upgraded shares of CME Group from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, October 9th. Finally, Rosenblatt Securities started coverage on shares of CME Group in a research report on Wednesday, September 5th. They issued a “neutral” rating and a $177.00 price target for the company. Five research analysts have rated the stock with a hold rating, nine have given a buy rating and one has given a strong buy rating to the company. CME Group currently has an average rating of “Buy” and an average target price of $182.69.

ILLEGAL ACTIVITY WARNING: “CME Group (NASDAQ:CME) Issues Quarterly Earnings Results, Beats Estimates By $0.03 EPS” was published by Baseball Daily News and is the sole property of of Baseball Daily News. If you are accessing this story on another domain, it was illegally stolen and republished in violation of US and international copyright & trademark law. The original version of this story can be accessed at https://www.baseballdailydigest.com/2018/11/10/cme-group-cme-issues-earnings-results.html.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Read More: Compound Annual Growth Rate (CAGR)

Earnings History for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply